In the Loop: Gabe's bell to 'honor the fighting, remember the resting, and party on with the survivors'
Gabe Carranza walked into the lobby on the 16th floor of the Mayo Building. It was a walk he'd made more times than he could count over the past three years and 70 days. But this walk was different. It marked the end of Gabe's treatment for?acute lymphoblastic leukemia. The lobby was filled with family, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 1, 2019 Category: Databases & Libraries Source Type: news
Five-year-old who won the nation’s heart in his battle against leukaemia has found a stem-cell donor
Oscar Saxelby-Lee, of St John's, Worcester, was diagnosed with the aggressive blood cancer acute lymphoblastic leukaemia on December 28 last year after his parents noticed bruising. (Source: the Mail online | Health)
Source: the Mail online | Health - March 29, 2019 Category: Consumer Health News Source Type: news
HSCT Remains Standard in Childhood ALL, Despite CAR T-Cells HSCT Remains Standard in Childhood ALL, Despite CAR T-Cells
Clinicians should continue to rely on matched donor stem cell transplants to treat childhood acute lymphoblastic leukemia, while more data on novel CAR T-cell therapies is gathered, says German expert.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Favorable Outcomes Seen in Long Term for ALLR3 Trial
Findings for risk - stratified tx in B - cell precursor acute lymphoblastic leukemia, late bone marrow relapse (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 19, 2019 Category: Cancer & Oncology Tags: Oncology, Pathology, Pediatrics, Journal, Source Type: news
Favorable Outcomes Seen in Long Term for ALLR3 Trial
TUESDAY, March 19, 2019 -- For children with B-cell precursor acute lymphoblastic leukemia with late bone marrow relapse, risk stratification by minimal residual disease seems to be an effective strategy for treatment, according to a study recently... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2019 Category: Pharmaceuticals Source Type: news
Only About Half of Elderly Newly Diagnosed With ALL Receive Tx
FRIDAY, March 8, 2019 -- Almost half of elderly patients newly diagnosed with acute lymphoblastic leukemia (ALL) do not receive treatment, according to a study recently published in Leukemia& Lymphoma.
Christopher Kim, M.P.H., Ph.D., from Amgen... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2019 Category: Pharmaceuticals Source Type: news
Washington mom says she's cant vaccinate her five-year-old battling cancer and slams anti-vaxxers
Kai Bonneau, five, of Vancouver, Washington, has been battling acute lymphoblastic leukemia. He can't receive any vaccines until he's done with chemotherapy treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - March 5, 2019 Category: Consumer Health News Source Type: news
Genetic Variant Tied to Leukemia Risk in Hispanic Children
Novel susceptibility locus identified in the ERG gene for acute lymphoblastic leukemia (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 25, 2019 Category: Cancer & Oncology Tags: Oncology, Pathology, Pediatrics, Journal, Source Type: news
Genetic Variant Tied to Leukemia Risk in Hispanic Children
MONDAY, Feb. 25, 2019 -- Genetic variations have been identified in the ERG gene that are associated with an increased risk for acute lymphoblastic leukemia (ALL) in Hispanic children, according to a study recently published in Blood.
Noting that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 25, 2019 Category: Pharmaceuticals Source Type: news
Mother claims she took her daughter to the GP FIVE TIMES before she was diagnosed with leukaemia
Sharon Mcalister, 35, of Rutherglen, South Lanarkshire, alleges she took her daughter Kaiann to three separate GPs five times before the youngster was told she had acute lymphoblastic leukaemia. (Source: the Mail online | Health)
Source: the Mail online | Health - February 25, 2019 Category: Consumer Health News Source Type: news
Genetic variations in a fourth gene linked to elevated leukemia risk in Hispanic children
(St. Jude Children's Research Hospital) Progress reported on understanding why Hispanic children are more likely to develop acute lymphoblastic leukemia and to die of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 14, 2019 Category: Cancer & Oncology Source Type: news
Obesity Linked to Adverse Events in Children With Leukemia
WEDNESDAY, Feb. 13, 2019 -- For children with acute lymphoblastic leukemia (ALL), obesity is associated with an increased risk for adverse events during premaintenance chemotherapy, according to a study published in the February issue of Pediatric... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 13, 2019 Category: Pharmaceuticals Source Type: news
Allogeneic Transplants No Benefit in Hypodiploid ALL Allogeneic Transplants No Benefit in Hypodiploid ALL
Children with hypodiploid acute lymphoblastic leukemia, a rare form of the disease with a poor prognosis, have no survival benefit from allogeneic transplant and should not undergo it, say US doctors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 25, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Addition of BMT Not Indicated in Some With Peds Hypodiploid ALL
WEDNESDAY, Jan. 23, 2019 -- For some children with hypodiploid acute lymphoblastic leukemia (ALL), allogeneic hematopoietic cell transplantation does not improve outcomes compared with chemotherapy alone, according to a study published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 23, 2019 Category: Pharmaceuticals Source Type: news
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
BLINCYTO is the First and Only Therapy for Minimal Residual Disease Approved in the European Union
Approval Based on Data From the Phase 2 BLAST Study, the Largest Prospective Trial in Minimal Residual Disease-Positive Acute Lymphoblastic Leukemia
TH... Biopharmaceuticals, Oncology, Regulatory Amgen, BLINCYTO, blinatumomab, Acute Lymphoblastic Leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2019 Category: Pharmaceuticals Source Type: news
